Cancer Research: TBXT and Beyond ASPIRE Awards

הגורם המממן
The Mark Foundation for Cancer Research
פרטי המכרז / קול קורא

The Mark Foundation for Cancer Research, in partnership with the Chordoma Foundation, is now accepting letters of intent for ASPIRE Awards focused on expanding the chordoma surfaceome. The initiative aims to unlock new treatment paradigms for chordoma and other TBXT-driven cancers by targeting TBXT-derived peptides presented by MHC (pMHC) and uncovering novel, tumor-specific surface antigens. 

Competitive proposals will generate broadly enabling datasets, tools, technologies, or mechanistic insights that facilitate the development of multiple therapeutic modalities. Areas of interest include basic and translational research and preclinical proof-of-concept studies that de-risk future therapeutic development. Awardees will have access to the Chordoma Foundation’s extensive research-enabling resources and disease models.

Funding: $500,000 over a 24-month term.

Informational webinar will be held on November 12, 2026, at 11 a.m.  EST. Register here.

 

הגשת LOI אפשרית עד 10.12.2026. 

תחומים
רפואה ומדעי החיים